Abstract
Lipoproteins have been traditionally classified based on their hydrated densities or electrophoretic mobilities. In the 1960s Alaupovic (1) proposed that plasma lipoproteins could be viewed as a system of particles characterized by their apolipoprotein composition. This concept evolved in the proposal of using “apolipoprotem profiles” for typing dyslipoproteinemias. Along these lines, several recent reports have shown that certain apolipoprotein profiles may be better predictors of lipoprotein disorders than the traditional lipid profiles (2). During the last decade, immunological methods have taken advantage of the specificity provided by polyclonal or monoclonal antibodies (PAbs, MAbs) to identify, separate, and measure specific lipoprotein particles directly in plasma (3). The application of these techniques to clinical and epidemiological studies has shown that these apolipoprotein-specific subclasses may be important diagnostic tools for dyslipoproteinemia, as well as useful predictors for coronary-artery disease (2, 4–6). Moreover, they may provide useful clues about the chemical nature of the corresponding lipoprotein particles
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alaupovic, P. (1968) Recent advances in metabolism of plasma lipoproteins chemical aspects. Prog. Biochem Pharmacol 4, 91–109.
Gotto, A. M. and Levy, R I (1983) Dyslipoproteinemias characterized by absent,excess, or aberrant apolipoproteins, in Proceedings of the Workshop on Apollpoprotein Quantijcation (Lippel, K., ed.), NIH Publication No. 83-1266, Chevy Chase, MD, pp 25–147
Fruchart, J C (1990) Lipoprotein heterogeneity and its effect on apolipoprotein assay Scand J Clin. Lab Invest 50, 51–57.
Fiévet, C, Méjean, L., Drouin, P., and Fruchart, J C (1988) Molecular analysis of atherogenic lipoprotein particles and atherosclerosis, in Eicosanoids, Apolipoproteins, Lipoprotein Particles and Atherosclerosis (Malmendier, C L and Alaupovic, P, eds.), Plenum, New York, pp. 279–282.
Parra, H J, Cachera, C., Equagoo, K, Dracon, M., Fruchart, J C, and Tacquet, A. (1988) Quantitative abnormalities of lipoprotein particles in chronic hemodialysis patients, in Eicosanoids, Apollpoproteins, Lipoprotein Particles and Atherosclerosis (Malmendier, C L, Alaupovic, P., eds.), Plenum, London, pp 283–287
Parra, H J, Arveiler, D., Evans, A. E, Cambou, J P., Amouyel, P., Bingham, A, McMaster, D, Schaffer, P., Douste-Blazy, P., Luc, G., Richard, J. L., Ducimetière, P, Fruchart, J C., and Cambien, F. (1992) A case control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease the ECTIM study. Arterioscler Thromb 12, 701–707.
Steinberg, K K, Cooper, G. R., Grasier, S R., and Rosseneu, M. (1983) Some considerations of methodology and standardization of apolipoprotein A-I immunoassays Clin Chem 29, 415–426.
Rosseneu, R, Vercaemst, R., Steinberg, K. K, and Cooper, G R (1983) Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem. 29, 427–433.
Marcovina, S. M., Albers, J J., Dati, F., Ledue T. B., and Ritchie, R. F. (1991) International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B Clin Chem 37, 1676–1682.
Marcovina, S. M., Albers, J. J., Henderson, L O, and Hannon W. H (1993) International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-I and B. III. comparability of apolipoprotein A-I values by use of international reference material Clin Chem 39, 773–781.
Alaupovic, P., McConathy, W. J., Currry, M. D., and Fesmire, J D (1982) Characterization of dyslipoproteinemias by apolipoprotein profiles, in Lipoproteins and Coronary Atherosclerosis (Noseda, G., Fragiacomo, C, Fumagalli, R, and Paoletti, R, eds.), Elsevier, Amsterdam, pp. 135–144
Alaupovic, P., Tavella, M., and Fesmire, J (1987) Separation and identification of apo B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias. Adv Exp Med. Biol 210, 7–14.
Cheung, M. C and Albers, J J (1982) Distribution of high density lipoprotein particles with different apoprotein composition. particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res 23, 747–753
Bekaert, E. D., Alaupovic, P., Knight-Gibson, C., Norum R. A., Laux, M J., and Ayrault-Jarrter, M (1992) Isolation and partial characterization of lipoprotein A-II (LpA-II) particles of human plasma Biochim Biophys Acta 1126, 105–113
Alaupovic, P (1981) David Rubinstein Memorial Lecture: the biochemical and chemical significance of the interrelationship between very low density and high density lipoproteins Can J Biochem. 59, 565–579.
Parsy, D, Dracon, M, Cachera, C., Parra, H J, Vanhoutte, G, Tacquet, A., and Fruchart, J. C (1988) Lipoprotein abnormalities in chronic hemodialysis patients. Nephrol Dial Transplant 3, 51–56.
Blankenhorn, D H, Alaupovic, P., Wickam, E, Chin, H P., and Azen, S P. (1990) Prediction of anglographic change in native human coronary arteries and aortocoronary bypass grafts. Circulation 81, 470–476.
Chivot, L, Mainard, F, Bigot, E., Bard, J M, Auget, J. L, Madec Y, and Fruchart, J. C. (1990) Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis 82, 205–211.
Alsayed, N and Rebourcet, R (1991) Abnormal concentrations of C-II, C-III, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients. Clin. Chem 37, 387–393
Genest, J. J., Bard, J. M., Fruchart, J. C., Ordovas, J M., Wilson, P F. N., and Schaefer, E J (1991) Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis 90, 149–157.
Warnick, G. R. and Albers, J J (1978) A comprehensive evaluation of the heparmmanganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19, 65–76.
Puchois, P., Luley, C, and Alaupovic, P. (1987) Comparison of four procedures for separating apohpoprotein A-and apolipoprotein B-containig lipoproteins in plasma Clin Chem 33, 1597–1602.
Graziam, M. S., Zanolla, L., Righetti, G., Marchetti, C, Zanotto, G., and Lupo, A (1994) Distribution of C-II and C-III peptides in lipoprotein classes. methods and clinical significance Clin Chem 40, 240–244.
McConathy, W. J. and Alaupovic, P. (1974) Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms. Febs Letters 41, 174–178
Luc, G, Fiévet, C, Arveiler, D., Evans, A E., Bard, J. M., Cambien, F., Fruchart, J C., and Duclmetière, P (1996) Apolipoproteins C-III and E in apo B-and non-apo B-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. J. Lipid Res 37, 508–517.
McConathy, W. J., Alaupovic, P., and Fesmire, J. C. (1983) Various applications of electroimmunoassay for plasma apolipoprotein, in Proceedings of the Workshop on Apolipoprotein Quantification (Lippel, K., ed), NIH Publication No. 83-1266, Chevy Chase, MD, pp. 276–2817.
Atmeh, R F, Shepherd, J, and Packard, C J. (1983) Subpopulations of apolipoprotein A-I in human high-density lipoproteins Their metabolic profiles and response to drug therapy Biochim. Biophys Acta 751, 175–188.
Parra, H. J., Mezdour, H., Ghalim, N., Bard, J. M, and Fruchart, J C. (1990) Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 36, 143l–1435.
Koren, E., Puchois, P, Alaupovic, P., Fesmue, J, Kandousst, A, and Fruchart, J C (1987) Quantification of two types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential antibody immunosorbent assay Clin Chem 33, 38–43
Kandoussi, A., Cachera, C., Parsy, D, Bard, J M, and Fruchart, J. C (1991) Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo C-III and apo B with apo E J Immunoassay 12, 305–323
Vu-Dac, N., Mezdour, H., Parra, H J, Luc, G., Luyeye, I, and Fruchart, J C (1989) A selective bt-site immunoenzymatic procedure for human Lp(a) lipoprotein quantification using monoclonal annbodies against apo (a) and apo B. J Lipid Res. 30, 1437–1444
Luyeye, I., Fiévet, C., DuPont, J. C, Durteux, C, Shmane, N., Lecocq, J. F, Demarquilly, C., and Fruchart J.C. (1988) Human apolipoprotein B. evidence for its immunochemical heterogeneity using monoclonal antibodies and an immunoenzymometric assay. Clin Biochem. 21, 255–261
Fiévet, C., Nuttens, M. C, Ducimetière, P., Fruchart, J C, Bertrand, M., and Salomez, J. L (1991) Relation of arteriographically defined coronary artery disease to serum lipoprotein paticles mapped with monoclonal antibodies. Circulation 84, 153–159
Nakane, P and Kawaai, J. (1974) Peroxidase labelled antibody, a new method of conjugation. J. Histochem Cytochem. 22, 1084–1091.
Markwell, M. A K, Haas, S. M., Bieber, L L., and Tolbert, N E (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87, 206–210.
Egusa, G, Brady, D W., Grundy, S. M., and Howard, B. V (1983) Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 24, 126l–l267.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Fievet, C., Fruchart, JC. (1998). Measurement of Lipoprotein Particles. In: Ordovas, J.M. (eds) Lipoprotein Protocols. Methods in Molecular Biology™, vol 110. Humana Press. https://doi.org/10.1385/1-59259-582-0:153
Download citation
DOI: https://doi.org/10.1385/1-59259-582-0:153
Publisher Name: Humana Press
Print ISBN: 978-0-89603-420-4
Online ISBN: 978-1-59259-582-2
eBook Packages: Springer Protocols